COVID19 Vaccine Trials

AstraZeneca Kids’ COVID Vaccine Trial Stopped Till Clotting Probe Ends 

  • Scientists have paused oxford vaccine trial in children over blood clotting issue
  • The trial in 6-17-year-olds isn’t stopped for safety concerns but to wait for more information.
  • Initial observations suggest a causal link between the vaccine and the clotting incidents.
  • Information regarding the clotting incidents will be available in the coming days.

According to a BBC report, a trial of the Oxford-AstraZeneca Covid vaccine on children has stopped giving out jabs while the UK’s medicines...

https://mfame.guru/astrazeneca-kids-covid-vaccine-trial-stopped-till-clotting-probe-ends/

WHO Approves Oxford COVID Vaccine Saying Benefits Outweighs Risks

  • WHO has approved AstraZeneca covid vaccines.
  • Studies show benefits outweigh risks.
  • The vaccine will be supplied through the global COVAX.
  • This is the 3rd vaccine to receive WHO approval
  • Meanwhile, Oxford researchers are starting the vaccine trials on children.

According to an ANI News report, the World Health Organisation (WHO) on Monday gave emergency use approval (EUA) to two versions of AstraZeneca-Oxford-developed COVID-19 vaccines, allowing these shots to be rolled out globally through...

https://mfame.guru/who-approves-oxford-covid-vaccine-saying-benefits-outweighs-risks/

Moderna Vs Pfizer – How the 2 COVID Vaccines Are Competing?

The United States now has two vaccines available for emergency use and the Science News Erin Garcia de Jesus sought to find out the difference between the two. 

Here’s an excerpt from her analysis. 

Moderna & Pfizer Authorization

On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency use in people 18 years or older. The decision follows a thumbs-up vote from a panel of experts that convened on December 17 to discuss vaccine data that the biotechnology...

https://mfame.guru/moderna-vs-pfizer-how-the-2-covid-vaccines-are-competing/

Going Once! Going Twice! Another COVID Vaccine Cracks the Deal

Now, there are two covid vaccines that are effective, that’s how the Pulitzer award winning Science magazine reported Moderna’s covid vaccine triumph just after the Pfizer Vaccine results. 

What is it?

Another COVID-19 vaccine using the same previously unproven technology as the vaccine from Pfizer and BioNTech, the U.S. and German companies that reported success on 9 November, appears to work remarkably well. And this time, the maker, U.S. biotech Moderna, is releasing a bit more data to back...

https://mfame.guru/going-once-going-twice-another-covid-vaccine-cracks-the-deal/

2 Doses of Pfizer COVID Vaccine in 28 Days Prevents Corona

In a major development, Drugmaker Pfizer said on Monday that an early look at data from its coronavirus vaccine shows it is more than 90% effective — a much better than expected efficacy if the trend continues, reports CNN. 

What did the interim analysis find?

The so-called interim analysis looked at the first 94 confirmed cases of Covid-19 among the more than 43,000 volunteers who got either two doses of the vaccine or a placebo. It found that fewer than 10% of infections were in participants...

https://mfame.guru/2-doses-of-pfizer-covid-vaccine-in-28-days-prevents-corona/

AstraZeneca COVID Vaccine Safety Report on Participant’s Illness

AstraZeneca's Oxford vaccine trial to resume, the university says

CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial, says an article published on their website.

What’s in the report?The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later,...

https://mfame.guru/astrazeneca-covid-vaccine-safety-report-on-participants-illness/

Johnson & Johnson COVID Vaccine 99% Efficient in Single Dose

Shares of Johnson & Johnson rally after opioid fine

There is some good news on Johnson & Johnson’s coronavirus vaccine as trials show even one dose of their vaccine is effective against the virus, reports CNN.

What the trial result shows?
  • Early results from a Phase 1/2a clinical trial show it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants.
  • The trial included two age groups: 18- to 55-year-olds and 65 and older, and looked at the safety and side effects of two different doses.

https://mfame.guru/johnson-johnson-covid-vaccine-99-efficient-in-single-dose/

Oxford Resumes AstraZeneca COVID19 Vaccine Trial

Rules and guidance meeting up - 11 Sept
  • The oxford vaccine trial is set to resume after being cleared by the UK Health department
  • The trials were stopped earlier this month when a participant developed spinal cord problems
  • The company has refused to give details of the participant but has assured that an independent investigation is being done.
  • The investigation is done to understand whether the illness developed due to the vaccine or other issues
  • The participant hasn’t disclosed whether she had this condition before.
  • Meanwhile,...

https://mfame.guru/oxford-resumes-astrazeneca-covid19-vaccine-trial/

Fauci Underlines Legitimate Ways To Stop COVID Vaccine Trials Early

According to a CNN report, Dr. Anthony Fauci, the nation’s top infectious disease official, in an interview with KHN has said that a COVID-19 vaccine could be available earlier than expected if ongoing clinical trials produce overwhelmingly positive results.Trials To End Early?

Although two ongoing clinical trials of 30,000 volunteers are expected to conclude by the end of the year, Fauci said an independent board has the authority to end the trials weeks early if interim results are...

https://mfame.guru/fauci-underlines-legitimate-ways-to-stop-covid-vaccine-trials-early/

HIV Community Calls for Inclusion in COVID19 Vaccine Trials

According to an article published in the Science Magazine, the HIV community is not pleased with how they have kept away from the coronavirus vaccine trials and feels they should be part of it as they are one of the most vulnerable groups.

As large trials get underway to test the vaccines needed to stop the global coronavirus pandemic, one group has realized it is being left out and is not happy: people living with HIV.

Why this exclusion?

Several companies pursuing a COVID-19 vaccine—including...

https://mfame.guru/hiv-community-call-for-inclusion-in-covid19-vaccine-trials/